Virtual Journal Club

Please note: This website is for discussion purposes only. The information provided at this website is not intended to provide treatment advice, or to diagnose or treat any medical disorder. The creator of this website is not responsible for events that occur as a result of decisions made based on the information presented here.

Citations powered by PubMed

Facing up to toxic epidermal necrolysis.

August 19th, 2010 · Start a Discussion

Related Articles

Facing up to toxic epidermal necrolysis.

Expert Opin Pharmacother. 2010 Aug 13;

Authors: Piérard GE, Paquet P

Toxic epidermal necrolysis (TEN) is a rare but life-threatening mucocutaneous adverse drug reaction. The disease is characterized by a specific and extensive destruction of the epidermis and mucosal epithelia, particularly of the mouth, genitalia and eyes. The TEN pathomechanism is probably initiated by a toxic drug metabolism inside keratinocytes, leading to a self-activation of apoptosis and necrosis. These events are boosted by additional effects of T lymphocytes and macrophages. At present there is still a lack of validated mainstay treatment for TEN. However, a few treatment modalities have been reported to halt TEN progression in some patients.

PMID: 20707598 [PubMed - as supplied by publisher]

Link to Abstract at PubMed

Share


Tags: Expert Opin Pharmacother

0 responses so far ↓

  • There are no comments yet...Kick things off by filling out the form below.

Discuss this article